Tandem Diabetes Care to Present at Two Major Healthcare Conferences
Event summary
- Tandem Diabetes Care will present at BofA Securities Health Care Conference on May 12, 2026.
- The company will also present at Goldman Sachs Global Healthcare Conference on June 8, 2026.
- Both presentations will be webcast live and archived for 30 days.
- Tandem's portfolio includes the Tandem Mobi system and t:slim X2 insulin pump with Control-IQ+ technology.
The big picture
Tandem Diabetes Care's upcoming conference appearances come at a time when the diabetes technology market is increasingly focused on advanced automated insulin delivery systems. The company's presentations will likely highlight its technological advancements and market positioning amidst growing competition in the space. With a focus on reducing the burden of diabetes management, Tandem aims to solidify its role as a key player in the insulin delivery sector.
What we're watching
- Market Positioning
- How Tandem's presentations will emphasize its competitive edge in automated insulin delivery systems.
- Technology Adoption
- The pace at which Control-IQ+ technology is being adopted by patients and healthcare providers.
- Investor Sentiment
- Whether the presentations will shift investor perception of Tandem's growth prospects.
Related topics